2025 AGENDA

Jeff Wade, JD, Chairman, BioHouston

Brad Burke, Associate Vice President, Industry & New Ventures, Rice Innovation, Ion; Executive Director, Rice Alliance for Technology and Entrepreneurship
 

William McKeon, President and CEO, Texas Medical Center

Introduction: Patrick Clayton, PhD, Vice President, Life Sciences and Healthcare Startup Banking, J.P. Morgan

Moderator: Annie Sendejo, Vice President, Life Sciences Banking, J.P. Morgan

Barbara Alcaraz Silva, PhD, Executive Director, Life Sciences and Healthcare Startup Banking, J.P. Morgan

Sean MacGregor JD, Executive Director, Healthcare Investment Banking, J.P. Morgan

Fixnip US

Roam Technologies

Respiree

OsseoLabs

Aspira Medical

OUI-Medical

Liquet Medical

Endomedix

Dynamic Light

Sarah Hein, PhD, Cofounder & CEO, March Biosciences

Suma Gopinathan, PhD, MPharm, Senior Vice President, Discovery, Lexicon Pharmaceuticals (Nasdaq: LXRX)

Michael Torosian, JD, Partner, Baker Botts

SingleCell Biotechnology

Train Genomics

Acuamark Diagnostics

MobilityZ Health

PDC Remote Care

Alwayslab

Moderator: Emily Reiser, PhD, Strategy and New Ventures, Texas Medical Center

Bryson Saéz, MBA, Life Science - Investor Lead, HAN and Venture Partner, Novellus Ventures

Fred Shane, CEO, Axil Capital Advisors

Drew Yashar, Senior Associate, Life Sciences, Capital Factory

Pothik Chatterjee, MBA, Executive Director, Digital Health Institute, Rice University and Methodist Hospital 

Khurram Nasir, MD, MPH, Chief, Cardiovascular Prevention and Wellness, Houston Methodist Hospital, Co-Director, Houston Methodist-Rice Digital Health Institute, Professor of Medicine, Weill Cornell Medical College

John “JR” Reale, Jr., Managing Director for Startup Engagement, Rice Alliance for Technology and Entrepreneurship

Kristen Doyle JD, MTSC, CEO, Cancer Prevention and Research Institute of Texas (CPRIT)

Ken Smith, PhD, JD, MBA, Chief Product Development Officer, Cancer Prevention and Research Institute of Texas (CPRIT)

Victoria Ford, MPA, CEO, Texas Healthcare and Bioscience Institute

 

PHIOGEN

Miracle Regeneratives

NKILT Therapeutics

InterAct Therapeutics

Velvet Therapeutics

Tomahawk Oncology

Oncotherics

IonTX

PaxImmune Therapeutics

OmniNano Pharmaceuticals

Raymond Miller, JD, Partner, U.S. Chair, Life Sciences Patent Development and Strategy, DLA Piper 

Michael Dilling, PhD, MBA, Executive Director of Commercialization, BCM Innovation Institute

SageSpectra

Cardiost

Modulate Technologies

Xander Medical

Previze.AI

OptiLung

(fka Additive Biomedical)

Freyya

Panelists:

Joe Petrosino, PhD, Chief Scientific Innovation Officer, Baylor College of Medicine

Bruce Butler, PhD, Vice President, Research and Technology Director, Office of Technology Management, UT Health

Vineet Gupta, PhD, Vice President for Innovation & Tech Development & Transfer, UTMB

Emily Barnhill, MHA, Vice President, Strategic Industry Ventures, MD Anderson 

Moderator: Suzanne Tomlinson-Mathis, PhD, MBA, Director, Research Programs and Strategic Initiatives, Gulf Coast Consortia for Quantitative Biomedical Science

Moderator: Verena Kallhoff, PhD, MBA, Sr. Director, Global Life Sciences, Greater Houston Partnership

Shawn Cloonan, JD, Co-Life Science Lead and General Counsel, McCord Development

Chris Wild, PhD, Assistant Vice Chancellor/Vice President, San Jacinto College

Danielle Scheiner, Vice President, Regional Economic Development, Greater Houston Partnership

Bectas Therapeutics

4M Therapeutics

HydroGene Therapeutics

ENB Therapeutics

Ypsilon Tx

Oticara

CrossBridge Bio

Circurna

Moderator: Scott Nudelman, Co-founder and Managing Principal, Vitrian

Donna Chang, CEO, Hope Biosciences

Federica Giordano, PhD, Director of Clinical Operations, March Biosciences

Ricardo Jimenez, SVP, Technical Operations, Neurogene

Laine Linden, Head of Technical Operations, CTMC 

Allterum Therapeutics

7 Hills Pharma

Persevere Therapeutics

PINOVA Therapeutics

Orphagen Pharmaceuticals

Iterion Therapeutics

Indapta Therapeutics

Medley Therapeutics

Bob Radinsky, PhD, Vice President, Global Head, Oncology External Innovation, Johnson & Johnson 

Ten Most Promising Life Science Companies - Presented by Verena Kallhoff, PhD, MBA, Senior Director, Global Life Sciences, Greater Houston Partnership

Michael E. DeBakey Award - Presented by BioHouston

People’s Choice Award - Presented by Stephanie Gan, Director of Governance and Partnerships, Health Emergency Readiness Canada, Innovation Science and Economic Development Canada